drugset / Trial / NCT02335294
A Study of TRV130 for the Treatment of Pain After Abdominoplasty
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain following abdominoplasty.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-07
- Completion
- 2015-08
Outcome
Met primary endpoint
release “Phase 2b trial of TRV130 in moderate to severe acute postoperative pain after abdominoplasty surgery. The study achieved its primary endpoint” trevena.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | — | — |
| Subject | Oliceridine | Other / unclassified | — | Intravenous |
Indications
No indication recorded.